Author Archive for: panglobal

Entries by panglobal

Biotium launches first ever mounting media with far-red nuclear counterstain and autofluorescence quenching reagent

5 August 2021 in /by

  Biotium, a leading provider of reagents for immunofluorescence microscopy, is significantly expanding its line of antifade wet-set and hardset EverBrite Mounting Medium with options that include Biotium’s new far-red NucSpot 640 nuclear counterstain. In addition, Biotium is also releasing EverBrite TrueBlack Hardset Mounting Medium for mounting and quenching of lipofuscin autofluorescence in a single […]

Vacuum Vortex Concentration methodology – how it works

5 August 2021 in /by

Solvent evaporation specialists – BioChromato has published online a description of how the Vacuum Vortex Concentration (VVC) methodology enables users of its Smart Series of Evaporators remove high boiling solvents including water, DMSO and DMF quickly and safely. At the heart of each BioChromato Smart Evaporator is a highly efficient spiral airflow created by a […]

Gyros Protein Technologies and Cygnus Technologies expand collaboration, introduce new HEK 293 HCP Assay Reagent Set

5 August 2021 in /by

Gyros Protein Technologies (part of Mesa Labs’ Biopharmaceutical Development Division), a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, has announced the next phase of its on-going collaboration with Cygnus Technologies, a Maravai LifeSciences company, and the introduction of a new HEK 293 HCP immunoassay solution. The Cygnus HEK 293 […]

Sysmex launches new automated blood coagulation analysers in EMEA region

26 July 2021 in /by

Sysmex Europe has launched two new automated blood coagulation analysers, CN-3500 and CN-6500, in specific countries in the EMEA region. They are targeted at medium- and large-scale hospitals and commercial labs, as well as other facilities, the company says. The new instruments come with a measuring unit that uses the chemiluminescence enzyme immunoassay (CLEIA) methodology […]

Avacta’s AffiDX SARS-CoV-2 Antigen Lateral Flow Test detects Delta variant with high sensitivity

22 July 2021 in /by

Avacta Group, the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer and pre|CISION platforms, says a recent study has shown that the AffiDX antigen lateral flow test detects the Delta variant of the SARS-CoV-2 virus in clinical samples. Lateral flow antigen tests are intended to provide a cost effective and rapid means […]

Bio-Rad introduces SEQuoia RiboDepletion Kit for next-gen sequencing

22 July 2021 in /by

Bio-Rad Laboratories has introduced the SEQuoia RiboDepletion Kit, which improves assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-Seq library. The SEQuoia RiboDepletion Kit is designed for genomics researchers targeting rare transcripts or working with a limited or degraded sample. The kit can retain RNA transcripts that could be lost when using […]

Biotage launches Biotage PhyPrep automated platform for plasmid DNA purification

22 July 2021 in /by

Biotage has launched their Biotage PhyPrep, a new automated platform for plasmid DNA purification that releases laboratory staff from the tedium of repetitive, manual labour – and takes full advantage of the PhyTip columns’ dual flow chromatography technology, to yield supercoiled, endotoxin-free, transfection-grade plasmid DNA. With the new Biotage PhyPrep platform, the automated process purifying plasmid […]

Japanese Patent Office upholds key Charpentier-Doudna CRISPR patent

22 July 2021 in /by

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, issued a statement saying that the Japanese Patent Office (JPO) has rejected arguments filed in opposition to the second Japanese patent (JP6692856) filed by Dr. Charpentier, together with The Regents of the University of […]

MIMETAS opens new Phenotypic Screening Centre

22 July 2021 in /by

MIMETAS, a leader in human-relevant organ-on-a-chip models, has opened their Phenotypic Screening Center. The centre facilitates large-scale screening campaigns on Organ-on-a-Chip models, a powerful technology that improves the human physiological relevance of cultured tissues by utilizing microfluidic techniques. In contrast to other Organ-on-a-Chip platforms, the MIMETAS OrganoPlate technology offers the scalability and the throughput needed […]

ProBioGen, LAVA Therapeutics close second cell line development agreement

22 July 2021 in /by

ProBioGen and LAVA Therpuetics N.V. have closed a second cell line development agreement to support a bispecific gamma-delta T cell engager (TCE) candidate in LAVA’s pipeline. Under the agreement and using its CHO.RiGHT expression platform, including its DirectedLuck Transposase technology for the generation of stable high-titer cell lines, ProBioGen will conduct cell line development of a novel […]

Latest issue of Clinical laboratory

November 2024

CLi Cover Nov 2024
Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
clinlab logo blackbg 1

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.